Technical developments have made crystallographic fragment screening the most effective method for screening fragment libraries. Here, we provide a brief overview of the method and its requirements.
The expansion of the drug discovery CRO market highlights the need to minimize costs and timelines in pharmaceutical drug development. Discover how SARomics Biostructures can help with this!
In this article, we discuss weak affinity chromatography (WAC™), the proprietary fragment screening technique jointly owned by SARomics Biostructures and Red Glead Discovery.
In this third post on structural biology and structure-based drug design we discuss fragment libraries and fragment-based lead discovery
It was a fantastic year for the company! We introduced new team members and new services, including WAC fragment screening…